If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.29    -0.01 (-3.33%)
Bid:
0.28
Ask:
0.30
Spread: 0.02 (7.143%)
Market Cap: £16.81m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Holding(s) in Company

2 Apr 2012 16:39

RNS Number : 6522A
CAP-XX Limited
02 April 2012
 



 

For filings with the FSA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

CAP-XX Ltd

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Change to the ISC

X

3. Full name of person(s) subject to thenotification obligation: iii

Henderson Global Investors

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

30 March 2012

6. Date on which issuer notified:

02 April 2012

7. Threshold(s) that is/are crossed orreached: vi, vii

Crossed below 10%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORD GBPNPV

7,781,575

7,781,575

7,781,575

9.01%

AU0000XINAS1

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

7,781,575

9.01%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Wayne Powell

15. Contact telephone number:

020 7818 5611

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLELLFBLZFXBBV
Date   Source Headline
3rd Nov 20239:05 amRNSResult of AGM and Directorate Change
3rd Nov 20237:05 amRNSAGM Trading Update
26th Oct 20232:05 pmRNSHolding(s) in Company
13th Oct 20239:45 amRNSNotice of AGM
4th Oct 20237:00 amRNSExpansion of sales operations
29th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
14th Sep 202312:29 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSPre-close Trading Update and Notice of Results
31st Jul 20239:53 amRNSHolding(s) in Company
18th Jul 202310:27 amRNSUpdate on Patent Infringement
30th Jun 20235:00 pmRNSTotal Voting Rights
13th Jun 20237:00 amRNSHolding(s) in Company
9th Jun 20237:53 amRNSAppointment of Chief Executive Officer
8th Jun 20238:38 amRNSHolding(s) in Company
8th Jun 20237:00 amRNSHolding(s) in Company
6th Jun 202311:38 amRNSHolding(s) in Company
2nd Jun 20238:36 amRNSResult of General Meeting
31st May 20235:00 pmRNSTotal Voting Rights
19th May 20237:00 amRNSHolding(s) in Company
16th May 20231:03 pmRNSHolding(s) in Company
16th May 20238:16 amRNSHolding(s) in Company
12th May 20239:18 amRNSGrant of share options
11th May 20237:00 amRNSAppointment of new Chief Executive Officer
5th May 20237:00 amRNSResult of Retail Offer and Total Voting Rights
4th May 20237:40 amRNSResult of Placing and Notice of General Meeting
3rd May 20234:54 pmRNSAnthony Kongats stepping down as CEO of CAP-XX
3rd May 20234:53 pmRNSREX Retail Offer
3rd May 20234:52 pmRNSProposed Placing and Subscription to raise £2.5m
25th Apr 20237:00 amRNSDistribution agreement with Digi-Key
18th Apr 20237:00 amRNSCAP-XX Achieves PSW from Continental Automotive
13th Apr 20237:00 amRNSHolding(s) in Company
28th Feb 202311:05 amRNSSecond Price Monitoring Extn
28th Feb 202311:00 amRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSInterim Results
23rd Feb 20237:00 amRNSAppointment of representative and distributor
15th Feb 20237:00 amRNSLaunch of 3V product targeting coin cell battery
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20232:05 pmRNSSecond Price Monitoring Extn
26th Jan 20232:00 pmRNSPrice Monitoring Extension
26th Jan 202310:32 amRNSTrading and Operational Update
6th Jan 202311:05 amRNSSecond Price Monitoring Extn
6th Jan 202311:00 amRNSPrice Monitoring Extension
13th Dec 20227:00 amRNSCAP-XX adds coin cell supercapacitors to portfolio
29th Nov 20227:00 amRNSEnergous and CAP-XX Partnership
23rd Nov 20227:00 amRNSR&D Tax Rebate
18th Nov 20227:00 amRNSDirector / PDMR Shareholding
15th Nov 20227:00 amRNSMARINE EDGE Selects CAP-XX Supercapacitor Modules
3rd Nov 20228:59 amRNSResult of AGM
3rd Nov 20227:00 amRNSUltra-small 5mm cylindrical supercapacitors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.